{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:34:12Z","timestamp":1758634452662},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.leukres.2003.10.011","type":"journal-article","created":{"date-parts":[[2003,12,9]],"date-time":"2003-12-09T11:55:53Z","timestamp":1070970953000},"page":"65-69","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S1","title":["A 2-year-old with atypical CML with a t(5;12)(q33;p13) treated successfully with imatinib mesylate"],"prefix":"10.1016","volume":"28","author":[{"given":"Brenda","family":"Wittman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Horan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Felgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Baylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bean","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2003.10.011_BIB1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2141.1996.396933.x","article-title":"Atypical chronic myeloid leukemia, a distinct clinical entity related to the myelodysplastic syndrome?","volume":"92","author":"Oscier","year":"1996","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2003.10.011_BIB2","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0950-3536(87)80031-8","article-title":"Haematological classification of the chronic myeloid leukemias","volume":"1","author":"Shepherd","year":"1987","journal-title":"Bailleire\u2019s Clin. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2003.10.011_BIB3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/A:1008393002748","article-title":"Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia","volume":"11","author":"Hernanzez","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2003.10.011_BIB4","doi-asserted-by":"crossref","unstructured":"Martiat P, Michaux JL, Rodhain J. Philadelphia-negative (Ph\u2212) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. Blood 78(1):205\u201311, 1.","DOI":"10.1182\/blood.V78.1.205.bloodjournal781205"},{"issue":"3\u20134","key":"10.1016\/j.leukres.2003.10.011_BIB5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/10428199709114162","article-title":"Clinical and biological aspects of Philadelphia negative\/BCR-negative chronic myeloid leukemia","volume":"25","author":"Costello","year":"1997","journal-title":"Leuk. Lymph."},{"key":"10.1016\/j.leukres.2003.10.011_BIB6","unstructured":"Vardiman JW. Myelodysplastic\/myeloproliferative diseases. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001 [Chapter 2]."},{"issue":"7","key":"10.1016\/j.leukres.2003.10.011_BIB7","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2003.10.011_BIB8","first-page":"134a","article-title":"Is atypical chronic myeloid leukemia a high white count myelodysplastic disorder?","volume":"10","author":"Shukralla","year":"1997","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2003.10.011_BIB9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000046641","article-title":"Myeloproliferative disorders with translocations of chromosome 5q31\u201335: role of the platelet-derived growth factor receptor beta","volume":"107","author":"Steer","year":"2002","journal-title":"Acta Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2003.10.011_BIB10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.leukres.2003.10.011_BIB11","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.leu.2401494","article-title":"The tel-PDGFR beta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice","volume":"13","author":"Ritchie","year":"1999","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2003.10.011_BIB12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI8902","article-title":"Fatal myeloproliferation, induced in mice by TEL\/PDGF[beta]R expression, depends on PDGF[beta]R tyrosines 579\/581","volume":"105","author":"Tomasson","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2003.10.011_BIB13","doi-asserted-by":"crossref","unstructured":"Weler PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 83(10):2759\u201379.","DOI":"10.1182\/blood.V83.10.2759.2759"},{"issue":"7","key":"10.1016\/j.leukres.2003.10.011_BIB14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa020150","article-title":"Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta","volume":"347","author":"Apperley","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2003.10.011_BIB15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.leukres.2003.10.011_BIB16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.leukres.2003.10.011_BIB17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.leukres.2003.10.011_BIB18","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603003266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T22:03:47Z","timestamp":1585346627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603003266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":18,"alternative-id":["S0145212603003266"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2003.10.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}